A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology

Issued on behalf of GT Biopharma, Inc. From bispecific ADCs at IDEAYA to a GSK partnership at Summit, B7-H3 has become one of the most actively pursued antigens in solid tumor oncology — and a new natural killer cell engager just entered the clinic SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) — USA News Group... The post A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology appeared first on Montreal Gazette .

Original source: Montreal Gazette